Muscle triglyceride and insulin resistance.

Skeletal muscle contains the majority of the body's glycogen stores and a similar amount of readily accessible energy as intramyocellular triglyceride (imTG). While a number of factors have been considered to contribute to the pathogenesis of insulin resistance (IR) in obesity and type 2 diabetes mellitus (DM), this review will focus on the potential role of skeletal muscle triglyceride content. In obesity and type 2 DM, there is an increased content of lipid within and around muscle fibers. Changes in muscle in fuel partitioning of lipid, between oxidation and storage of fat calories, almost certainly contribute to accumulation of imTG and to the pathogenesis of both obesity and type 2 DM. In metabolic health, skeletal muscle physiology is characterized by the capacity to utilize either lipid or carbohydrate fuels, and to effectively transition between these fuels. We will review recent findings that indicate that in type 2 DM and obesity, skeletal muscle manifests inflexibility in the transition between lipid and carbohydrate fuels. This inflexibility in fuel selection by skeletal muscle appears to be related to the accumulation of imTG and is an important aspect of IR of skeletal muscle in obesity and type 2 DM.

[1]  H. Lithell,et al.  Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men , 1994, Diabetologia.

[2]  J. Simoneau,et al.  Muscle fiber types of women after resistance training — Quantitative ultrastructure and enzyme activity , 1993, Pflügers Archiv.

[3]  N. Barzilai,et al.  Overfeeding rapidly induces leptin and insulin resistance. , 2001, Diabetes.

[4]  R. Kreis,et al.  Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  B. Goodpaster,et al.  Fat content in individual muscle fibers of lean and obese subjects , 2001, International Journal of Obesity.

[6]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[7]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[8]  H. Beck-Nielsen,et al.  Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes , 2001, Diabetologia.

[9]  S. Lemieux,et al.  Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. , 2001, Diabetes.

[10]  K. Frayn,et al.  Carbohydrate and fat have different effects on plasma leptin concentrations and adipose tissue leptin production. , 2001, Clinical science.

[11]  M. Laville,et al.  Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. , 2001, Diabetes.

[12]  Simon C Watkins,et al.  Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. , 2001, Diabetes.

[13]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[14]  É. Hajduch,et al.  Protein kinase B (PKB/Akt) – a key regulator of glucose transport? , 2001, FEBS letters.

[15]  J. Goldstein,et al.  Unsaturated Fatty Acids Down-regulate SREBP Isoforms 1a and 1c by Two Mechanisms in HEK-293 Cells* , 2001, The Journal of Biological Chemistry.

[16]  I. Batty,et al.  Ceramide impairs the insulin-dependent membrane recruitment of Protein Kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells , 2001, Diabetologia.

[17]  J. McGarry,et al.  Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. , 2001, Diabetes.

[18]  L. Meyer,et al.  Adipocyte and erythrocyte plasma membrane phospholipid composition and hyperinsulinemia: a study in nondiabetic and diabetic obese women , 2000, International Journal of Obesity.

[19]  G. Steinberg,et al.  Development of leptin resistance in rat soleus muscle in response to high-fat diets. , 2000, American journal of physiology. Endocrinology and metabolism.

[20]  H. Vidal,et al.  Adipocyte membrane phospholipids and PPAR-gamma expression in obese women: relationship to hyperinsulinemia. , 2000, American journal of physiology. Endocrinology and metabolism.

[21]  G. Cooney,et al.  Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[22]  I. Shimomura,et al.  Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R Ross,et al.  Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. , 2000, Journal of applied physiology.

[24]  B. Wolffenbuttel,et al.  Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[25]  Simon C Watkins,et al.  Intramuscular lipid content is increased in obesity and decreased by weight loss. , 2000, Metabolism: clinical and experimental.

[26]  B. Goodpaster,et al.  Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. , 2000, The American journal of clinical nutrition.

[27]  A. De Gaetano,et al.  Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. , 2000, Metabolism: clinical and experimental.

[28]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[29]  Rena R Wing,et al.  Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. , 1999, American journal of physiology. Endocrinology and metabolism.

[30]  G. Müller,et al.  Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. , 1999, European journal of biochemistry.

[31]  J. Simoneau,et al.  Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  A. Kriketos,et al.  Interrelationships between muscle fibre type, substrate oxidation and body fat , 1999, International Journal of Obesity.

[33]  P. Scifo,et al.  Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.

[34]  P. Else,et al.  What role for membranes in determining the higher sodium pump molecular activity of mammals compared to ectotherms? , 1999, Journal of Comparative Physiology B.

[35]  R. Coleman,et al.  Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/obmice. , 1999, American journal of physiology. Endocrinology and metabolism.

[36]  F. Schick,et al.  Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. , 1999, American journal of physiology. Endocrinology and metabolism.

[37]  I. Shimomura,et al.  Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. , 1999, Current opinion in lipidology.

[38]  J. Simoneau,et al.  Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  A. J. Hulbert,et al.  Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity. , 1998, Current opinion in clinical nutrition and metabolic care.

[40]  B. Kiens,et al.  Palmitate transport and fatty acid transporters in red and white muscles. , 1998, American journal of physiology. Endocrinology and metabolism.

[41]  F. Lönnqvist,et al.  Reduced gene expression of UCP2 but not UCP3 in skeletal muscle of human obese subjects , 1998, Diabetologia.

[42]  A. Golay,et al.  Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity , 1998, The Lancet.

[43]  E. Kraegen,et al.  Diet-Induced Muscle Insulin Resistance in Rats Is Ameliorated by Acute Dietary Lipid Withdrawal or a Single Bout of Exercise: Parallel Relationship Between Insulin Stimulation of Glucose Uptake and Suppression of Long-Chain Fatty Acyl-CoA , 1997, Diabetes.

[44]  B. Goodpaster,et al.  Subcutaneous Abdominal Fat and Thigh Muscle Composition Predict Insulin Sensitivity Independently of Visceral Fat , 1997, Diabetes.

[45]  L. Baur,et al.  Muscle fibre type composition in infant and adult populations and relationships with obesity , 1997, International Journal of Obesity.

[46]  J. Simoneau,et al.  Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. , 1997, Journal of applied physiology.

[47]  C. Newgard,et al.  Direct antidiabetic effect of leptin through triglyceride depletion of tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  C Boesch,et al.  In vivo determination of intra‐myocellular lipids in human muscle by means of localized 1H‐MR‐spectroscopy , 1997, Magnetic resonance in medicine.

[49]  N. Færgeman,et al.  Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. , 1997, The Biochemical journal.

[50]  E. Richter,et al.  Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. , 1997, The American journal of physiology.

[51]  J. McGarry,et al.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.

[52]  G. Shulman,et al.  Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. , 1996, The Journal of clinical investigation.

[53]  K. Nazar,et al.  Triacylglycerol synthesis in the different skeletal muscle fiber sections of the rat. , 1996, The American journal of physiology.

[54]  B. Fielding,et al.  Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. , 1996, Metabolism: clinical and experimental.

[55]  L. Mandarino,et al.  Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. , 1996, The American journal of physiology.

[56]  S. Lillioja,et al.  Skeletal muscle membrane lipid composition is related to adiposity and insulin action. , 1995, The Journal of clinical investigation.

[57]  S. Turner,et al.  Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. , 1995, The Journal of clinical investigation.

[58]  M. Suzuki,et al.  Beef tallow diet decreases beta-adrenergic receptor binding and lipolytic activities in different adipose tissues of rat. , 1995, Metabolism: clinical and experimental.

[59]  M. R. Murti,et al.  1.7–1.9 μm InxGa1−xAs/InyAl1−yAs light‐emitting diodes lattice‐mismatched grown on GaAs , 1995 .

[60]  J. Simoneau,et al.  Skeletal muscle utilization of free fatty acids in women with visceral obesity. , 1995, The Journal of clinical investigation.

[61]  J. Simoneau,et al.  Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  W. Winder,et al.  Effect of fasting and refeeding on acetyl-CoA carboxylase in rat hindlimb muscle. , 1995, Journal of applied physiology.

[63]  H. Khamis The Body-Mass Index as a Proxy for Fatness and Fat-Free Mass in Adults , 1995 .

[64]  J. Simoneau,et al.  Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[65]  W. Saris,et al.  beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. , 1994, The American journal of physiology.

[66]  E. Ravussin,et al.  Whole-body energy metabolism and skeletal muscle biochemical characteristics. , 1994, Metabolism: clinical and experimental.

[67]  L. Mandarino,et al.  Interaction between glucose and free fatty acid metabolism in human skeletal muscle. , 1993, The Journal of clinical investigation.

[68]  E. Ravussin,et al.  Relationship between skeletal muscle lipoprotein lipase activity and 24-hour macronutrient oxidation. , 1993, The Journal of clinical investigation.

[69]  D. Chisholm,et al.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.

[70]  J. Janosky,et al.  Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. , 1991, The American journal of clinical nutrition.

[71]  M. Mozzoli,et al.  Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. , 1991, The Journal of clinical investigation.

[72]  E. Kraegen,et al.  Influence of Dietary Fat Composition on Development of Insulin Resistance in Rats: Relationship to Muscle Triglyceride and ω-3 Fatty Acids in Muscle Phospholipid , 1991, Diabetes.

[73]  L. Mandarino,et al.  Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. , 1990, The Journal of clinical investigation.

[74]  P. Björntorp,et al.  Glucose tolerance and hyperinsulinaemia in obese women: role of adipose tissue distribution, muscle fibre characteristics and androgens , 1990, Journal of internal medicine.

[75]  J. Round,et al.  Muscle fibre type and aetiology of obesity , 1990, The Lancet.

[76]  C. Bouchard,et al.  Human variation in skeletal muscle fiber-type proportion and enzyme activities. , 1989, The American journal of physiology.

[77]  R. Zechner,et al.  Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. , 1988, The Journal of clinical investigation.

[78]  T. Watts,et al.  Insulin stimulates the dephosphorylation and activation of acetyl-CoA carboxylase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[79]  R. DeFronzo,et al.  Role of Lipid Oxidation in Pathogenesis of Insulin Resistance of Obesity and Type II Diabetes , 1987, Diabetes.

[80]  C Bogardus,et al.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. , 1987, The Journal of clinical investigation.

[81]  E R Weibel,et al.  Endurance training in humans: aerobic capacity and structure of skeletal muscle. , 1985, Journal of applied physiology.

[82]  W. Harris,et al.  Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia , 1985 .

[83]  D. James,et al.  Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. , 1985, The American journal of physiology.

[84]  S. Lillioja,et al.  Relationship between insulin-mediated glucose disposal and lipid metabolism in man. , 1985, The Journal of clinical investigation.

[85]  C. Zetterberg,et al.  Is there a change in relative muscle fibre composition with age? , 1984, Clinical physiology.

[86]  S. Lillioja,et al.  Correlation between muscle glycogen synthase activity and in vivo insulin action in man. , 1984, The Journal of clinical investigation.

[87]  G. Dagenais,et al.  Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. , 1976, The Journal of clinical investigation.

[88]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[89]  K. Zierler,et al.  Heterogeneity of forearm metabolism with special reference to free fatty acids. , 1962, The Journal of clinical investigation.

[90]  K. Zierler,et al.  The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. , 1956, The Journal of clinical investigation.